Lichtenburg Nut Company Business Plan — Conclusion and Recommendation

What the numbers support, what they do not, and the terms on which the plan recommends proceeding.

Section 34 of 37

Conclusion and Recommendation

Jump to section

A sound industrial proposition in a structurally unattractive industry, priced at close to fair value — which is to say, worth doing for the right investor and not for most

The commercial logic of this venture is sound. There is a real problem in the South African peanut butter category: a raw material that is structurally short and cannot be hedged, a quality failure record that has produced two recall cycles in twenty-four months, and a set of buyers who bear the consequences without controlling the chain. Vertical integration from contracted field to sealed jar is a genuine answer to that problem, not a marketing claim, and the July 2026 tariff decision has materially improved the economics of manufacturing domestically.

The financial logic is more qualified, and this document has tried to say so consistently rather than at the end. Peanut butter manufacture in South Africa requires roughly one rand of capital for each rand of annual revenue. On the 11.8% EBITDA margin the industry supports at this scale, a margin that sits credibly between RCL Foods and Tiger Brands — that capital intensity produces a return on invested capital of 9.5% in Year 5 and does not exceed the 15.1% cost of capital until FY2037. The ten-year discounted cash flow gives an enterprise value of R10.9m against R161.2 million of capital deployed. The project is, to a first approximation, worth what it costs.

33.1 For whom this investment is suitable

Suitable for

  • Development finance institutions. A ten-year equity IRR of 12.8% with strong employment, grower development, import substitution and food safety outcomes is a reasonable fit for a developmental mandate.
  • Strategic and trade investors. An integrated groundnut supply chain is a scarce asset. A buyer with existing distribution or an adjacent product range would realise synergies the standalone case cannot.
  • Family offices and patient industrial capital with a required return in the low to mid teens and a willingness to hold for eight to ten years through a slow ramp.
  • Agricultural sector investors seeking downstream exposure and a contracted route to market for groundnut production.

Not suitable for

  • Conventional private equity funds targeting a 20% to 25% rand IRR over three to five years. A Year 5 exit returns 3.9% at 6.5x and 10.6% at a strategic 8.0x. No reasonable adjustment closes that gap.
  • Investors requiring early income. No dividend is declared before Operating Year 7, and the first full-year net profit is in FY2032.
  • Investors who cannot fund a downside. The downside scenario requires a further R274.5 million and effectively writes off the initial equity.
  • Leveraged structures. The asset cannot support conventional gearing during the ramp, and the covenant headroom in the first years of amortisation is close to nil.

33.2 Recommendation

33.3 Summary of the case

R214m

FY2033 net revenue

12.3%

FY2038 EBITDA margin

12.8%

Ten-year equity IRR

19.2%

FY2038 ROIC

Table 82. The case for and against, side by side

The case for

The case against

A structural raw material and quality problem that vertical integration genuinely solves

An industry with severe buyer power, high supplier power and an entrenched incumbent

A 20-point tariff change six weeks old, improving domestic manufacturing economics

A capital intensity of roughly one rand per rand of revenue against a low-teens EBITDA margin

Defensive, staple demand across four in five households

Return on invested capital below the cost of capital until FY2037

A credible Year 10 EBITDA margin of 12.3% and ROIC of 19.2%

A Year 5 exit that returns 3.9% at a financial multiple

Four revenue streams from one production train, allowing mix to be managed

Customer concentration close to 50% in Operating Year 1

Government grant support and a strong developmental profile

A downside case that exhausts all facilities and writes off the equity

Scarcity value to a strategic acquirer

Covenant headroom of 0.08x in the tightest year